The DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.
Cancer statistics in China, 2015
Open accessAbstract
With increasing incidence and mortality, cancer is the leading cause of death in China and is a major public health problem. Because of China's massive population (1.37 billion), previous national incidence and mortality estimates have been limited to small samples of the population using data from the 1990s or based on a specific year. With high‐quality data from an additional number of population‐based registries now available through the National Central Cancer Registry of China, the authors analyzed data from 72 local, population‐based cancer registries (2009‐2011), representing 6.5% of the population, to estimate the number of new cases and cancer deaths for 2015. Data from 22 registries were used for trend analyses (2000‐2011). The results indicated that an estimated 4292,000 new cancer cases and 2814,000 cancer deaths would occur in China in 2015, with lung cancer being the most common incident cancer and the leading cause of cancer death. Stomach, esophageal, and liver cancers were also commonly diagnosed and were identified as leading causes of cancer death. Residents of rural areas had significantly higher age‐standardized (Segi population) incidence and mortality rates for all cancers combined than urban residents (213.6 per 100,000 vs 191.5 per 100,000 for incidence; 149.0 per 100,000 vs 109.5 per 100,000 for mortality, respectively). For all cancers combined, the incidence rates were stable during 2000 through 2011 for males (+0.2% per year; P = .1), whereas they increased significantly (+2.2% per year; P < .05) among females. In contrast, the mortality rates since 2006 have decreased significantly for both males (−1.4% per year; P < .05) and females (−1.1% per year; P < .05). Many of the estimated cancer cases and deaths can be prevented through reducing the prevalence of risk factors, while increasing the effectiveness of clinical care delivery, particularly for those living in rural areas and in disadvantaged populations. CA Cancer J Clin 2016;66:115–132. © 2016 American Cancer Society.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Thyroid carcinomas are more prevalent among women.”
From Restoration of p53 using the novel MDM2-p53 antagonist APG115 suppresses dedifferentiated papillary thyroid cancer cells (2017) · cites this paper as [4]
Citations
Cites
Jemal, A., Bray, F., Ferlay, J., Ward, E., & Forman, D. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 55,044
Self-citationGlobal cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,858
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
Self-citation中華人民共和国国家統計局 (1988) · Medical Entomology and Zoology · Cited by 12,443
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,854
Self-citationSEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,404
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
The Health consequences of smoking—50 years of progress : a report of the Surgeon General
Lushniak, B. D., Samet, J. M., Pechacek, T. F., Norman, L., & Taylor, P. A. (2014) · Cited by 4,990
Flagged first, then by citations
2 of the 85 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- National Cancer Center, Disease Prevention and Control Bureau, Ministry of Health, 2012, Chinese Cancer Registry Annual Report 2012
- Ferlay J, 2005, Check and Conversion Programs for Cancer Registries (IARC/IACR Tools for Cancer Registries). IARC Technical Report No. 42
- Chen Z, 2008, National Death Survey Report 2004–2005
- 2015, Will China make the great leap in tobacco control in 2015 [editorial]?, Lancet., 385, 2122
- Kang LN, 2014, Cancer screening and prevention in China [serial online], Cancer Control 2014., 131
Cited by
Sorted by citations
Items 201–300 of 1,032
Antecedents and consequences of panic buying: The case of COVID‐19
Prentice, C., Quach, S., & Thaichon, P. (2020) · International Journal of Consumer Studies · doi:10.1111/ijcs.12649 · Cited by 235
Ma, X., Wei, J., Gu, D., Zhu, Y., Feng, B., Liang, M., Wang, S., Zhao, X., & Tian, J. (2019) · European Radiology · doi:10.1007/s00330-018-5985-y · Cited by 220
Ni, W., Zhang, Y., Zhan, Z., Feng, Y., Liang, Y., Huang, J., Chen, K., Chen, L., & Ding, Y. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0449-4 · Cited by 214
Prognostic value of RDW in cancers: a systematic review and meta-analysis
Hu, L., Li, M., Ding, Y., Pu, L., Liu, J., Jingxin, X., Cabanero, M., Li, J., Xiang, R., & Xiong, S. (2016) · Oncotarget · doi:10.18632/oncotarget.13784 · Cited by 218
Personalized detection of circling exosomal PD-L1 based on Fe3O4@TiO2 isolation and SERS immunoassay
Pang, Y., Shi, J., Yang, X., Wang, C., Sun, Z., & Xiao, R. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111800 · Cited by 216
Pei, X., Wang, X., & Li, H. (2018) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.06.033 · Cited by 215
Wang, G., Liu, W., Zou, Y., Wang, G., Deng, Y., Luo, J., Zhang, Y., Li, H., Zhang, Q., Yang, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.062 · Cited by 213
Histologic subtype classification of non-small cell lung cancer using PET/CT images
Han, Y. K., Ma, Y., Wu, Z., Zhang, F., Zheng, D., Liu, X., Tao, L., Liang, Z., Yang, Z., Li, X., et al. (2020) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-04771-5 · Cited by 218
Radiation-Induced Normal Tissue Damage: Oxidative Stress and Epigenetic Mechanisms
Wei, J., Wang, B., Wang, H., Meng, L., Zhao, Q., Li, X., Xin, Y., & Jiang, X. M. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3010342 · Cited by 230
Wang, D., Hu, X., Xiao, L., Long, G., Yao, L., Wang, Z., & Zhou, L. (2020) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-019-04492-7 · Cited by 210
LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis
Wang, Y., Wu, S., Zhu, X., Zhang, L., Deng, J., Li, F., Guo, B., Zhang, S., Wu, R., Zhang, Z., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190950 · Cited by 231
Self-citationSun, Z., Ou, C., Liu, J., Chen, C., Zhou, Q., Yang, S., Li, G., Wang, G., Song, J., Li, Z., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0628-y · Cited by 209
RetractedZhang, X., Wang, J., Shao, G., Wang, Q., Qu, X., Wang, B., Moy, C. H., Fan, Y., Albertyn, Z., Huang, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09762-1 · Cited by 210
Lan, C., Shen, J., Wang, Y., Li, J., Liu, Z., He, M., Cao, X., Ling, J., Huang, J., Zheng, M., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01920 · Cited by 210
Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
Dhanasekaran, R., Nault, J., Roberts, L. R., & Zucman‐Rossi, J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.11.001 · Cited by 205
tRF‐Leu‐CAG promotes cell proliferation and cell cycle in non‐small cell lung cancer
Shao, Y., Sun, Q., Liu, X., Wang, P., Wu, R., & Ma, Z. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12994 · Cited by 212
Liu, Q., Li, F., Zhuang, Y., Xu, J., Wang, J., Mao, X., Zhang, Y., & Liu, X. (2019) · Gut Pathogens · doi:10.1186/s13099-018-0281-6 · Cited by 216
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)
Sun, H., Zhou, J., Wang, Z., Liu, X., Xie, Q. M., Jia, W., Zhao, M. D., Bi, X., Gong, L., Bai, X., et al. (2022) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-21-328 · Cited by 210
Self-citationWang, W. J., Chen, D., Jiang, M. Z., Xu, B., Li, X. W., Chu, Y., Zhang, Y. J., Mao, R., Liang, J., & Fan, D. M. (2018) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12576 · Cited by 206
SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway
Tian, S., Peng, P., Li, J., Deng, H., Zhan, N., Zeng, Z. R., & Dong, W. (2020) · Aging · doi:10.18632/aging.102831 · Cited by 206
Huang, Y., Zhang, J., Hou, L., Wang, G., Liu, H., Zhang, R., Chen, X., & Zhu, J. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0666-2 · Cited by 205
RetractedA review on methods for diagnosis of breast cancer cells and tissues
He, Z., Chen, Z., Tan, M., Sauli, E., Liu, Y., Li, T., Deng, Y., He, N., Li, S., Fu, J., et al. (2020) · Cell Proliferation · doi:10.1111/cpr.12822 · Cited by 216
Chao, B., Ju, X., Zhang, L., Xu, X., & Zhao, Y. F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00766 · Cited by 211
Luo, X., Wu, K., & He, X. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01968-w · Cited by 210
Lung cancer in never smokers—the East Asian experience
Zhou, F., & Zhou, C. (2018) · Translational Lung Cancer Research · doi:10.21037/tlcr.2018.05.14 · Cited by 217
Li, R., Ke, S., Meng, F., Lü, J., Zou, X., He, Z., Wang, W.-F., & Fang, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0852-y · Cited by 201
Xie, C., Zhou, X., Liang, C., Li, X., Ge, M., Chen, Y., Yin, J. J., Zhu, J., & Zhong, C. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02069-4 · Cited by 203
Hu, Y., Guo, Y., Wang, Y., Yu, J., Li, J., Zhou, S., & Chang, C. (2018) · Medical Physics · doi:10.1002/mp.13268 · Cited by 205
Gut microbiota and colorectal cancer
Gao, R., Gao, Z., Huang, L., & Qin, H. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2881-8 · Cited by 205
Prognostic alternative mRNA splicing signature in non-small cell lung cancer
Li, Y., Sun, N., Lu, Z., Sun, S., Huang, J., Chen, Z., & He, J. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.016 · Cited by 198
Self-citationEpidemiology of gynecologic cancers in China
Jiang, X., Tang, H., & Chen, T. (2017) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2018.29.e7 · Cited by 200
Clinical and translational advances in esophageal squamous cell carcinoma
Reichenbach, Z. W., Murray, M. G., Saxena, R., Farkas, D. T., Karassik, E. G., Klochkova, A., Patel, K., Tice, C. M., Hall, T. M., Gang, J., et al. (2019) · Advances in cancer research · doi:10.1016/bs.acr.2019.05.004 · Cited by 198
Ren, S., Wei, G., Liu, D., Wang, L., Hou, Y., Zhu, S., Peng, L., Zhang, Q., Cheng, Y., Su, H. L., et al. (2017) · European Urology · doi:10.1016/j.eururo.2017.08.027 · Cited by 198
Li, Y., Wu, Z., Yuan, J., Sun, L., Li, L., Huang, N., Bin, J., Liao, Y., & Liao, W. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.035 · Cited by 197
Circular RNA circ-LDLRAD3 as a biomarker in diagnosis of pancreatic cancer
Yang, F., Liu, D., Guo, J., Ge, N., Zhu, P., Liu, X., Wang, S., Wang, G., & Sun, S. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i47.8345 · Cited by 196
Zhang, X., Zeng, Q., Cai, W., & Ruan, W. (2021) · BMC Public Health · doi:10.1186/s12889-021-10907-5 · Cited by 206
Xie, Y., Gao, Q., Cai, G. X., Sun, X. M., Zou, T.-H., Chen, H. M., Yu, S.-Y., Qiu, Y.-W., Gu, W.-Q., Chen, X. Y., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.10.005 · Cited by 195
CircRNA hsa_circ_100395 regulates miR-1228/TCF21 pathway to inhibit lung cancer progression
Chen, D., Ma, W., Ke, Z., & Xie, F. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1515553 · Cited by 195
Zheng, X. W., Wang, Q., Zhou, Y., Zhang, D., Geng, Y., Hu, W., Wu, C., Shi, Y., & Jiang, J. (2022) · 癌症:英文版 · doi:10.1002/cac2.12363 · Cited by 196
Zhang, K., Shi, H., Xi, H., Wu, X., Cui, J., Gao, Y., Liang, W., Hu, C., Liu, Y., Li, J., et al. (2016) · Theranostics · doi:10.7150/thno.16044 · Cited by 192
Hong, W., Liang, L., Gu, Y., Qi, Z., Qiu, H., Yang, X., Zeng, W., Ma, L., & Xie, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.10.002 · Cited by 192
A systematic review on ethnomedicines of anti-cancer plants
Tariq, A., Sadia, S., Pan, K., Ullah, I., Mussarat, S., Sun, F., Olatunji, O. A., Altanzagas, B., Li, Z., Song, D., et al. (2017) · Phytotherapy Research · doi:10.1002/ptr.5751 · Cited by 193
The distribution and prevalence of human papillomavirus in women in mainland China
Li, K., Li, Q., Song, L., Wang, D., & Yin, R. (2019) · Cancer · doi:10.1002/cncr.32003 · Cited by 190
Wickstrøm, K., Kampffmeyer, M., & Jenssen, R. (2020) · Medical Image Analysis · doi:10.1016/j.media.2019.101619 · Cited by 185
Lan, C., Wang, Y., Xiong, Y., Li, J.-D., Shen, J.-X., Li, Y.-F., Zheng, M. H., Zhang, Y.-N., Feng, Y.-L., Liu, Q., et al. (2018) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30349-8 · Cited by 189
Conversion therapy and maintenance therapy for primary hepatocellular carcinoma
Zhou, H., & Song, T. (2021) · BioScience Trends · doi:10.5582/bst.2021.01091 · Cited by 191
Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer
Zhu, L., Zhu, Y., Han, S., Chen, M., Song, P., Dai, D., Xu, W., Jiang, T., Feng, L., Shin, V. Y., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1585-2 · Cited by 187
FABP5 promotes lymph node metastasis in cervical cancer by reprogramming fatty acid metabolism
Zhang, C., Liao, Y., Liu, P., Du, Q., Liang, Y., Ooi, S., Qin, S., He, S., Yao, S., & Wang, W. (2020) · Theranostics · doi:10.7150/thno.44868 · Cited by 186
Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma
Guo, M., Zhang, H., Zheng, J., & Liu, Y. (2020) · Journal of Cancer · doi:10.7150/jca.39972 · Cited by 185
Guo, X., Lv, X., Ru, Y., Zhou, F., Wang, N., Xi, H., Zhang, K., Li, J., Chang, R., Xie, T., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.1133 · Cited by 185
Agile convolutional neural network for pulmonary nodule classification using CT images
Zhao, X., Liu, L., Qi, S., Teng, Y., Li, J., & Qian, W. (2018) · International Journal of Computer Assisted Radiology and Surgery · doi:10.1007/s11548-017-1696-0 · Cited by 190
Cancer burden and trends in China: A review and comparison with Japan and South Korea
Sun, D., Cao, M., Li, H., He, S., & Chen, W. (2020) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2020.02.01 · Cited by 184
Self-citationNovel nanomedicines to overcome cancer multidrug resistance
Su, Z., Dong, S., Zhao, S., Liu, K., Tan, Y., Jiang, X., Assaraf, Y. G., Qin, B., Chen, Z., & Zou, C. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2021.100777 · Cited by 187
MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway
Yu, T., Zhao, Y., Hu, Z., Li, J., Chu, D., Zhang, J., Li, Z., Chen, B., Zhang, X., Pan, H., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0671 · Cited by 182
Geng, Y., Zhu, D., Wu, C., Wu, J., Wang, Q., Li, R., Jiang, J., & Wu, C. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.002 · Cited by 189
Li, C., Wan, L., Liu, Z., Xu, G., Wang, S., Su, Z., Zhang, Y., Zhang, C., Liu, X., Lei, Z., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.036 · Cited by 181
Liu, X., Wu, J., Zhang, D., Bing, Z., Tian, J., Ni, M., Zhang, X., Meng, Z., & Liu, S. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00265 · Cited by 181
Is it possible to halve the incidence of liver cancer in China by 2050?
Shi, J., Cao, M., Wang, Y., Bai, F., Lei, L., Peng, J., Feletto, E., Canfell, K., Qu, C., & Chen, W. (2020) · International Journal of Cancer · doi:10.1002/ijc.33313 · Cited by 180
Self-citationPrognostic significance of lymphocyte to monocyte ratio in colorectal cancer: A meta-analysis
Tan, D., Fu, Y., Tong, W., & Li, F. (2018) · International Journal of Surgery · doi:10.1016/j.ijsu.2018.05.030 · Cited by 181
Peng, Y., Wang, Y., Tang, N., Sun, D., Lan, Y., Yu, Z., Zhao, X., Feng, L., Zhang, B., Jin, L., et al. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0926-9 · Cited by 183
Jiang, Y., Jiang, Y., Li, C.-Q., Zhang, Y., Dakle, P., Hp, K., Deng, J.-W., Lin, R. Y., Yan, Y., Xie, J.-J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.050 · Cited by 186
Jin, P., Huang, Y., Zhu, P., Zou, Y., Shao, T., & Wang, O. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.07.081 · Cited by 178
Zhang, Y., Shan, G., Zhang, Y.-X., Cao, S.-J., Zhu, S. N., Li, H.-J., Ma, D., & Wang, D. X. (2018) · British Journal of Anaesthesia · doi:10.1016/j.bja.2018.05.059 · Cited by 178
Zhai, L.-Y., Li, M., Pan, W., Chen, Y., Li, M., Jian-xin, P., Zheng, L., Chen, J.-X., & Duan, W. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b12725 · Cited by 182
Wu, S., Zhang, L., Deng, J., Guo, B., Li, F., Wang, Y., Wu, R. T., Zhang, S., Lü, J., & Zhou, Y. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3440 · Cited by 182
Self-citationLiu, Y., Guo, Y., Wu, Z., Feng, K., Tong, C., Wang, Y., Dai, H., Shi, F., Yang, Q., & Han, W. (2020) · Cytotherapy · doi:10.1016/j.jcyt.2020.04.088 · Cited by 179
Ju, W., Zheng, R., Zhang, S., Zeng, H., Sun, K., Wang, S., Chen, R., Li, L., Wei, W., & He, J. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2218-x · Cited by 176
“, 2013) and previous studies from NCCR (Chen et al., 2016).”
MethodResultInfluentialSelf-citationShan, Q., Hu, H.-T., Feng, S., Peng, Z., Chen, S., Zhou, Q., Li, X., Xie, X., Lu, M., Wang, W., et al. (2019) · Cancer Imaging · doi:10.1186/s40644-019-0197-5 · Cited by 175
Zhou, T., Liang, X., Wang, P., Hu, Y., Qi, Y., Jin, Y., Du, Y., Fang, C., & Tian, J. (2020) · ACS Nano · doi:10.1021/acsnano.0c01453 · Cited by 173
Deep learning for lungs cancer detection: a review
Javed, R., Abbas, T., Khan, A. H., Daud, A. Y., Bukhari, A. A., & Alharbey, R. (2024) · Artificial Intelligence Review · doi:10.1007/s10462-024-10807-1 · Cited by 174
“(Chen et al. 2016).”
Saikosaponin A Inhibits Breast Cancer by Regulating Th1/Th2 Balance
Zhao, X., Liu, J., Ge, S., Chen, C., Li, S., Wu, X., Feng, X., Wang, Y., & Cai, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00624 · Cited by 173
Ding, P., Guo, H., Sun, C., Yang, P., Kim, N. H., Tian, Y., Liu, Y., Liu, P., Li, Y., & Zhao, Q. (2022) · BMC Gastroenterology · doi:10.1186/s12876-022-02199-9 · Cited by 183
Zhu, J., Zeng, Y., Li, W., Qin, H., Lei, Z., Shen, D., Gu, D., Huang, J., & Liu, Z. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0591-1 · Cited by 173
Wei, W., Jian, P.-E., Li, S., Guo, Z., Zhang, Y., Ling, Y., Lin, X., Xu, L., Shi, M., Zheng, L., et al. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0331-y · Cited by 175
Li, J., Dong, D., Fang, M., Wang, R., Tian, J., Li, H., & Gao, J. (2020) · European Radiology · doi:10.1007/s00330-019-06621-x · Cited by 172
Peng, Y., Xu, Y., Zhang, X., Deng, S., Yuan, Y., Luo, X., Hossain, M. T., Zhu, X., Du, K., Hu, F., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01457-w · Cited by 175
MicroRNA-140-5p inhibits invasion and angiogenesis through targeting VEGF-A in breast cancer
Lü, Y., Qin, T., Li, J. S., Wang, L., Zhang, Q., Jiang, Z., & Mao, J. (2017) · Cancer Gene Therapy · doi:10.1038/cgt.2017.30 · Cited by 170
LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling
Tang, J., Li, Y., Sang, Y., Yu, B., Lv, D., Zhang, W., & Feng, H. (2018) · Oncogene · doi:10.1038/s41388-018-0310-4 · Cited by 170
A Review of Resveratrol as a Potent Chemoprotective and Synergistic Agent in Cancer Chemotherapy
Xiao, Q., Zhu, W., Feng, W., Lee, S. S., Leung, A. W., Shen, J., Gao, L., & Xu, C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01534 · Cited by 172
Yang, S., Ma, S., Dou, H., Liu, F., Zhang, S., Jiang, C., Xiao, M., & Huang, Y. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111983 · Cited by 169
Self-citationSilencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7
Tang, W., Ji, M., He, G., Yang, L., Niu, Z., Jian, M., Wei, Y., Ren, L., & Xu, J. (2017) · OncoTargets and Therapy · doi:10.2147/ott.s131597 · Cited by 167
GLUT1 regulates cell glycolysis and proliferation in prostate cancer
Xiao, H., Wang, J., Yan, W., Cui, Y., Chen, Z., Gao, X., Wen, X., & Chen, J. (2017) · The Prostate · doi:10.1002/pros.23448 · Cited by 166
Xu, G., Zhang, B., Ye, J., Cao, S., Shi, J., Zhao, Y. D., Wang, Y., Sang, J., Yao, Y., Guan, W., et al. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.33750 · Cited by 167
Prognostic implications of autophagy-associated gene signatures in non-small cell lung cancer
Liu, Y., Wu, L., Ao, H., Zhao, M., Leng, X., Liu, M., Ma, J., & Zhu, J. (2019) · Aging · doi:10.18632/aging.102544 · Cited by 168
SNHG16 contributes to breast cancer cell migration by competitively binding miR-98 with E2F5
Cai, C., Huo, Q., Wang, X., Chen, B., & Yang, Q. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.02.094 · Cited by 166
Redox/pH dual-stimuli responsive camptothecin prodrug nanogels for “on-demand” drug delivery
Qu, Y., Chu, B., Wei, X., Lei, M., Hu, D., Zha, R., Zhong, L. X., Wang, M., Wang, F., & Qian, Z. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.016 · Cited by 166
Wang, L., Yang, S., Yang, S., Zhao, C., Tian, G., Gao, Y., Chen, Y., & Lu, Y. (2019) · World Journal of Surgical Oncology · doi:10.1186/s12957-019-1558-z · Cited by 167
Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer
Fan, X., Jin, Y., Chen, G., Ma, X., & Zhang, L. (2020) · Digestion · doi:10.1159/000508328 · Cited by 176
Swain, C. K. (2024) · Discover Environment · doi:10.1007/s44274-024-00030-8 · Cited by 185
“Pollution indices can be used to get a sense of how bad things are at a certain location, but picking the right one depends on factors like how dangerous it would be to use it [36, 53, 55, 74].”
InfluentialZhang, C., Peng, L., Zhang, Y., Liu, Z., Li, W., Chen, S., & Li, G. (2017) · Medical Oncology · doi:10.1007/s12032-017-0963-9 · Cited by 165
Liu, Z., Chen, Z., Fan, R., Jiang, B., Chen, X., Chen, Q., Nie, F., Lu, K., & Sun, M. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0651-6 · Cited by 165
Metastatic prostate cancer remains incurable, why?
Dong, L., Zieren, R. C., Xue, W., de Reijke, T. M., & Pienta, K. J. (2018) · Asian journal of urology · doi:10.1016/j.ajur.2018.11.005 · Cited by 177
Tobacco and the lung cancer epidemic in China
Parascandola, M. J., & Xiao, L. (2019) · Translational Lung Cancer Research · doi:10.21037/tlcr.2019.03.12 · Cited by 165
Wang, R., Sun, Y., Yu, W., Yan, Y., Qiao, M., Jiang, R., Guan, W., & Wang, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0995-9 · Cited by 164
Cai, Z., Chen, G., Zeng, Y., Dong, X., Li, Z., Huang, Y., Xin, F., Qiu, L., Xu, H., Zhang, W. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3477 · Cited by 164
Liu, W., Xie, L., He, Y.-H., Wu, Z.-Y., Liu, L.-X., Bai, X., Deng, D.-X., Xu, X., Liao, L.-D., Lin, W., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25202-5 · Cited by 178
Interactions between gastric microbiota and metabolites in gastric cancer
Dai, D., Yang, Y., Yu, J., Dang, T., Qin, W., Teng, L., Ye, J., & Jiang, H. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04396-y · Cited by 169
Cancer incidence and mortality: A cohort study in China, 2008–2013
Pan, R., Zhu, M., Yu, C., Lv, J., Guo, Y., Bian, Z., Yang, L., Chen, Y., Hu, Z., Chen, Z., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30825 · Cited by 163
Cheng, X., Li, M., Rao, X., Zhang, W., Li, X., Wang, L., & Huang, G. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s180954 · Cited by 163
Immune suppression in chronic hepatitis B infection associated liver disease: A review
Li, T.-Y., Yang, Y., Zhou, G. F., & Tu, Z. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i27.3527 · Cited by 167
Metadata
- Authors
- Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J.
- Affiliations
- Deputy Director, National Office for Cancer Prevention and Control National Cancer Center Beijing China
- Associate Researcher, National Office for Cancer Prevention and Control National Cancer Center Beijing China
- Cancer Council Queensland (AU)
- Associate Professor, National Office for Cancer Prevention and Control National Cancer Center Beijing China
- Centre international de recherche sur le cancer (FR)
- American Cancer Society (US)
- The University of Sydney (AU)
- Director National Cancer Center Beijing China.
- Corresponding author
- Chen, Wanqing
- ORCID
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2016-01-25
- Volume
- 66
- Issue
- 2
- Pages
- 115-132
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2272984102
- Cited by
- 17,038
- References
- 85
- Citations by year
- 2026: 142 · 2025: 461 · 2024: 1006 · 2023: 1271 · 2022: 1900 · 2021: 2470 · 2020: 2710 · 2019: 2630 · 2018: 2296 · 2017: 1648 · 2016: 486
- FWCI
- 1269.33
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- CA A Cancer Journal for Clinicians (publishedVersion)
- PubMed (publishedVersion)
- Griffith Research Online (submittedVersion, other-oa)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Funders
- National Health and Family Planning Commission of China
- Ministry of Science and Technology (2014FY121100)
- Topics
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Financial Impacts of Cancer
- Keywords
- cancer incidence, cancer mortality, cancer burden estimation, lung cancer, gastric cancer, esophageal cancer, liver cancer, urban-rural differences, cancer incidence trends, population-based cancer registry, cancer prevention, China
- MeSH terms
- Adult, Aged, China, Esophageal Neoplasms, Female, Humans, Liver Neoplasms, Lung Neoplasms, Male, Middle Aged, Neoplasms, Risk Factors, Rural Population, Stomach Neoplasms, Urban Population, Incidence, Prevalence, Survival Rate, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review